https://doi.org/10.4081/jbr.2011.4665

A soluble form of CTLA-4 is present in serum of pediatric patients with acute lymphoblastic leukaemia

Vol. 84 No. 1 (2011)
Submitted: August 7, 2014
Accepted: August 7, 2014
Published: January 30, 2011
soluble CTLA-4, acute lymphoblatic leukemia
Abstract Views: 723
PDF: 503
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

R. Simone
C. Tenca
F. Fais
G. De Rossi
G. Pesce
M. Bagnasco
D. Saverino
daniele.saverino@unige.it
CTLA-4 can regulate and maintain self-telerance, providing a negative signal limiting immunoresponses. Acute lymphoblastic leukemia is a clonal disorder of lymphoid progenitors representing the most frequent malignancy of childhood. Here, we show the presence of significantly elevated levels of a soluble form of CTLA-4 in 70% of B-ALL patients. A possible role of this soluble molecule in the pathogenesis of this neoplastic disease can be envisaged.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite

Simone, R., Tenca, C., Fais, F., De Rossi, G., Pesce, G., Bagnasco, M., & Saverino, D. (2011). A soluble form of CTLA-4 is present in serum of pediatric patients with acute lymphoblastic leukaemia. Journal of Biological Research - Bollettino Della Società Italiana Di Biologia Sperimentale, 84(1). https://doi.org/10.4081/jbr.2011.4665

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.